drugset / Trial / NCT00033358
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer
RandomizedParallel-groupOpen-labelPrevention
Summary
Randomized phase II trial to compare two different hormone therapy regimens in preventing endometrial cancer in women who have a genetic risk for hereditary nonpolyposis colon cancer. Hormone therapy may prevent the development of endometrial cancer in women with a genetic risk for hereditary nonpolyposis colon cancer. It is not yet known which hormone therapy regimen is more effective in preventing endometrial cancer.
Timeline
- Start
- 2002-02
- Primary completion
- 2007-10
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Norgestrel | Unknown | — | Oral |
| Subject | ethinyl estradiol | Small molecule | — | Oral |
| Subject | medroxyprogesterone acetate | Other / unclassified | — | Intramuscular |